Clinical Trial: Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06868290) titled 'Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA' on March 07.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: ANCA Associated Vasculitis (AAV)

Intervention: BIOLOGICAL: Rapcabtagene autoleucel

Single infusion of rapcabtagene autoleucel

OTHER: Active Comparator

Active comparator option as per protocol

DRUG: Glucocorticoids

Concomi...